SIGY · Sigyn Therapeutics, Inc. · Holdings
$0.03
0.00 (-6.27%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of $17,379,978 at September 30, 2025, had a working capital deficit of $3,903,920 at September 30, 2025, had net losses of $578,503 and $2,698,254, and $1,196,923 and $2,817,394 for the three and nine months ended September 30, 2025 and 2024, respectively, and net cash used in operating activities of $646,208 and $582,218 for the nine months ended September 30, 2025 and 2024, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$56,188
Shares
1.61M
Volume · Oct 2
27.05K
Avg daily vol (3M)
30.56K
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
Holders: 1
Total Value: $1,961
Total Shares: 53,000
Holder Concentration
Across 1 13F filersTop Holder
100.0%
of institutional value
Top 5
100.0%
of institutional value
Top 10
100.0%
of institutional value
HHI
10,000
Highly concentrated
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Mid Howard Capital Management Group, LLC | $1,961 | 100.00% | 53,000 | Shares | 2026-07-16 |